Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  deferasirox
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-10 of 10 for your search:
Start Over
Evaluation the Effect of Exjade on Oxidative Stress in Low Risk Myelodysplastic Syndrome Patients With Iron Over Load
Phase: Phase IV
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: CICL670A2412-HMO-CTIL, NCT00452660
Efficacy and Safety of Deferasirox in Patients With Myelodysplastic Syndrome and Transfusion-dependent Iron Overload
Phase: Phase IV
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CICL670ADE03, NCT00481143
Evaluating the Efficacy of Deferasirox in Transfusion Dependent Chronic Anaemias (Myelodysplastic Syndrome, Beta-thalassaemia Patients) With Chronic Iron Overload
Phase: Phase IV
Type: Supportive care
Status: Completed
Age: 18 to 80
Sponsor: Pharmaceutical / Industry
Protocol IDs: CICL670AHU02, NCT00564941
Magnetic Resonance Imaging (MRI) Assessments of the Heart and Liver Iron Load in Patients With Transfusion Induced Iron Overload
Phase: Phase IV
Type: Diagnostic, Supportive care
Status: Completed
Age: 16 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CICL670AAU01, NCT00673608
A Study Assessing the Efficacy and Safety of Deferasirox in Patients With Transfusion-dependent Iron Overload
Phase: Phase III
Type: Biomarker/Laboratory analysis, Supportive care
Status: Completed
Age: 2 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CICL670A2409, 2004-003953-16, NCT00171821
Safety, Tolerability, and Efficacy of Deferasirox in MDS
Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: MDS0306, NCT00469560
Study for the Treatment of Transfusional Iron Overload in Myelodysplastic Patients
Phase: Phase II
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CICL670AUS02, NCT00117507
Study of Deferasirox for Treatment of Transfusional Iron Overload in Myelodysplastic Patients
Phase: Phase II
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CICL670AUS03, UCLA-0508054-01, NOVARTIS-CICL670AUS03, NCT00110266
Evaluating Use of Deferasirox as Compared to Deferoxamine in Treating Cardiac Iron Overload
Phase: Phase II
Type: Supportive care
Status: Completed
Age: 10 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CICL670A2206, 2007-000766-20, NCT00600938
Deferasirox in Treating Iron Overload Caused By Blood Transfusions in Patients With Hematologic Malignancies
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Supportive care
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CCCWFU 97710, NCI-2010-02228, NCT01273766
Start Over